The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

Still, TV remains the industry's primary advertising format, with over $4 billion spent in the past year, led by blockbuster ...

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA ...

A new study has revealed that GLP-1 drugs, commonly used for diabetes and weight loss, show promise in treating alcohol ...

A healthy high protein prepared meal including chicken, carrots, fruits and greens. Taking Wegovy (semaglutide) can be a ...

As a new study finds that people who stopped taking semaglutide, the active ingredient in the new blockbuster weight loss ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

After easing diabetes and weight loss journey for many, the popular medications Ozempic and Wegovy have shown fresh promise ...

Then there’s physical activity: Many of the symptoms of lupus, such as joint pain, fatigue, and depression, may make patients ...

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...